Neurologists' attitudes regarding rt-PA for acute ischemic stroke.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 9596018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We studied the attitudes of 238 Texas neurologists regarding the use of recombinant tissue plasminogen activator (rt-PA). The results show that 38 (16%) had treated stroke patients with rt-PA, and 97% of these would do so again. In the group that had not treated patients, 60% would treat if a suitable candidate presented. We conclude that soon after FDA approval of rt-PA, two-thirds of survey respondents were using or were planning to use this therapy. Those neurologists who have used rt-PA for stroke report a positive experience.
Medical subject headings
- Health Care Surveys
- Health Knowledge, Attitudes, Practice
- Ischemic Attack, Transient
- Neurology
- Tissue Plasminogen Activator